 And Johnson & Johnson stock is popping 3%. The pharmaceutical giant beat expectations for its second quarter earnings. The sales of cancer drugs helping drive stronger than expected results. And shares of Five Below are tumbling over 20%. The discount teen-centric retailer replaced its longtime chief executive and cut its second quarter outlook. Five Below says inflation and high interest rates are taking a toll on shoppers. That's your Fox Business Report. I'm Hillary Barsky, invested in you.